WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.

Disclosures for additional planners can be found here.

Faculty

Eric S.G. Stroes, MD, PhD

Professor of Vascular Medicine
Amsterdam University Medical Centers
University of Amsterdam
Amsterdam, the Netherlands

Disclosures

Eric S.G. Stroes, MD, PhD, has the following relevant financial relationships:
Consultant or advisor for: Amgen, Inc.; AstraZeneca Pharmaceuticals LP; Daiichi Sankyo, Inc.; Esperion Therapeutics, Inc.; Merck; Novartis
Speaker or member of speakers bureau for: Akcea Therapeutics-Ionis Pharmaceuticals; Amgen, Inc.; AstraZeneca Pharmaceuticals LP; Daiichi Sankyo, Inc.; Esperion Therapeutics, Inc.; Merck; Novartis; Novo Nordisk; Sanofi-Regeneron Pharmaceuticals, Inc.
Research funding from: Ionis Pharmaceuticals; Novo Nordisk

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI

Director of Mount Sinai Heart
Dr Valentin Fuster Professor of Cardiovascular Medicine
Icahn School of Medicine at Mount Sinai Health System
New York, New York, United States

Disclosures

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI, has the following relevant financial relationships:
Consultant or advisor for: Angiowave, Bayer, Boehringer Ingelheim, Cardax, CellProthera, Cereno Scientific, High Enroll, Janssen, Level Ex, McKinsey, Merck, MyoKardia, NirvaMed, Novo Nordisk, PhaseBio, PLx Pharma, Regado Biosciences, Stasys; Broadview Ventures, Hims, Inc.
Research funding from: Abbott, Acesion Pharma, Afimmune, Aker Biomarine, Amarin, Amgen, AstraZeneca, Bayer, Beren, Boehringer Ingelheim, Boston Scientific, Bristol- Myers Squibb, Cardax, CellProthera, Cereno Scientific, Chiesi, CinCor, Cleerly, CSL Behring, Eisai, Ethicon, Faraday Pharmaceuticals, Ferring Pharmaceuticals, Forest Laboratories, Fractyl, Garmin, HLS Therapeutics, Idorsia, Ironwood, Ischemix, Janssen, Javelin, Lexicon, Lilly, Medtronic, Merck, Moderna, MyoKardia, NirvaMed, Novartis, Novo Nordisk, Owkin, Pfizer, PhaseBio, PLx Pharma, Recardio, Regeneron, Roche, Sanofi, Stasys, Synaptic, The Medicines Company, Youngene, 89Bio
Contracted researcher for: Abbott, Biotronik, Boston Scientific, CSI, Endotronix, St. Jude Medical (now Abbott), Philips, SpectraWAVE, Svelte, Vascular Solutions
Patent beneficiary of: Sotagliflozin
Stock options from: Angiowave; DRS.LINQ
Owns stock (privately owned) in: High Enroll
Owns stock (publicly traded) in: Bristol Myers Squibb
Other: Board of Directors: Angiowave, Bristol Myers Squibb, DRS.LINQ, High Enroll, TobeSoft; Data Safety Monitoring Committees: Asesion Pharma, Boston Scientific, Contego Medical, Novartis

Editor

Anne M. Sendaydiego, PharmD

Medical Education Director, WebMD Global, LLC

Disclosures

Anne M. Sendaydiego, PharmD, has no relevant financial relationships.

Compliance Reviewer

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Associate Director, Accreditation and Compliance

Disclosures

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

CPD

The Simple Mathematics of Lipid-Lowering Therapies and Targets in ASCVD: What Every Healthcare Professional Needs to Know

Authors: Eric S.G. Stroes, MD, PhD; Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
CPD Released: 8/17/2023
Valid for credit through: 8/17/2024, 11:59 PM EST

Start Activity

Credits Available

Non-US Physicians - maximum of 0.50 CPD

You Are Eligible For
- Letter of Completion

Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US cardiologists, primary care physicians, endocrinologists/diabetologists, nephrologists, and nurses.

The goal of this activity is that the learner will be better able to describe the amount of LDL-C reduction that is expected from lipid-lowering therapy (LLT) and appropriately use LLT to achieve target LDL-C goals.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- LDL-C targets in patients with dyslipidemia, including those at high and very high risk for atherosclerotic cardiovascular disease (ASCVD) events
- Percentage reduction in LDL-C that can be expected with LLT, as monotherapy or in combination
Have greater competence related to
- The use of LLT to achieve appropriate LDL-C reductions based on patient ASCVD risk and expected reductions of therapies

Disclosures

Disclosures for additional planners can be found here.

Faculty

Eric S.G. Stroes, MD, PhD

Professor of Vascular Medicine
Amsterdam University Medical Centers
University of Amsterdam
Amsterdam, the Netherlands

Disclosures

Eric S.G. Stroes, MD, PhD, has the following relevant financial relationships:
Consultant or advisor for: Amgen, Inc.; AstraZeneca Pharmaceuticals LP; Daiichi Sankyo, Inc.; Esperion Therapeutics, Inc.; Merck; Novartis
Speaker or member of speakers bureau for: Akcea Therapeutics-Ionis Pharmaceuticals; Amgen, Inc.; AstraZeneca Pharmaceuticals LP; Daiichi Sankyo, Inc.; Esperion Therapeutics, Inc.; Merck; Novartis; Novo Nordisk; Sanofi-Regeneron Pharmaceuticals, Inc.
Research funding from: Ionis Pharmaceuticals; Novo Nordisk

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI

Director of Mount Sinai Heart
Dr Valentin Fuster Professor of Cardiovascular Medicine
Icahn School of Medicine at Mount Sinai Health System
New York, New York, United States

Disclosures

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI, has the following relevant financial relationships:
Consultant or advisor for: Angiowave, Bayer, Boehringer Ingelheim, Cardax, CellProthera, Cereno Scientific, High Enroll, Janssen, Level Ex, McKinsey, Merck, MyoKardia, NirvaMed, Novo Nordisk, PhaseBio, PLx Pharma, Regado Biosciences, Stasys; Broadview Ventures, Hims, Inc.
Research funding from: Abbott, Acesion Pharma, Afimmune, Aker Biomarine, Amarin, Amgen, AstraZeneca, Bayer, Beren, Boehringer Ingelheim, Boston Scientific, Bristol- Myers Squibb, Cardax, CellProthera, Cereno Scientific, Chiesi, CinCor, Cleerly, CSL Behring, Eisai, Ethicon, Faraday Pharmaceuticals, Ferring Pharmaceuticals, Forest Laboratories, Fractyl, Garmin, HLS Therapeutics, Idorsia, Ironwood, Ischemix, Janssen, Javelin, Lexicon, Lilly, Medtronic, Merck, Moderna, MyoKardia, NirvaMed, Novartis, Novo Nordisk, Owkin, Pfizer, PhaseBio, PLx Pharma, Recardio, Regeneron, Roche, Sanofi, Stasys, Synaptic, The Medicines Company, Youngene, 89Bio
Contracted researcher for: Abbott, Biotronik, Boston Scientific, CSI, Endotronix, St. Jude Medical (now Abbott), Philips, SpectraWAVE, Svelte, Vascular Solutions
Patent beneficiary of: Sotagliflozin
Stock options from: Angiowave; DRS.LINQ
Owns stock (privately owned) in: High Enroll
Owns stock (publicly traded) in: Bristol Myers Squibb
Other: Board of Directors: Angiowave, Bristol Myers Squibb, DRS.LINQ, High Enroll, TobeSoft; Data Safety Monitoring Committees: Asesion Pharma, Boston Scientific, Contego Medical, Novartis

Editor

Anne M. Sendaydiego, PharmD

Medical Education Director, WebMD Global, LLC

Disclosures

Anne M. Sendaydiego, PharmD, has no relevant financial relationships.

Compliance Reviewer

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Associate Director, Accreditation and Compliance

Disclosures

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

For Physicians

The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).

Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

From Medscape Education

CPD

The Simple Mathematics of Lipid-Lowering Therapies and Targets in ASCVD: What Every Healthcare Professional Needs to Know

Authors: Eric S.G. Stroes, MD, PhD; Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAIFaculty and Disclosures

CPD Released: 8/17/2023

Valid for credit through: 8/17/2024, 11:59 PM EST

processing....

Educational Impact Challenge

Please answer the questions below to self-assess your knowledge. Answering these questions again after the activity will allow you to see what you learned.

Page 1 of 4

CPD Information Download Slides

Activity Transcript

Print
Like Tweet

Activity Transcript

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred.

The material presented here does not necessarily reflect the views of WebMD, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been authorized by the European Medicines Agency for use in Europe, off-label uses of authorized products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Faculty

Eric S.G. Stroes, MD, PhD

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI

Editor

Anne M. Sendaydiego, PharmD

Compliance Reviewer

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Peer Reviewer

CPD

The Simple Mathematics of Lipid-Lowering Therapies and Targets in ASCVD: What Every Healthcare Professional Needs to Know

Credits Available

You Are Eligible For

Target Audience and Goal Statement

Disclosures

Faculty

Eric S.G. Stroes, MD, PhD

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI

Editor

Anne M. Sendaydiego, PharmD

Compliance Reviewer

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Peer Reviewer

Accreditation Statements

For Physicians

Instructions for Participation and Credit

The Simple Mathematics of Lipid-Lowering Therapies and Targets in ASCVD: What Every Healthcare Professional Needs to Know

Educational Impact Challenge